Innoviva (INVA) FCF Margin Growth (5y) (2016 - 2026)
Innoviva (INVA) FCF Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -532,163.00 |
| Sep 30, 2025 | -3,644.00 |
| Jun 30, 2025 | -5,713.00 |
| Mar 31, 2025 | -3,853.00 |
| Sep 30, 2024 | -3,890.00 |
| Jun 30, 2024 | -4,437.00 |
| Mar 31, 2024 | 134,653.00 |
| Sep 30, 2023 | -4,958.00 |
| Jun 30, 2023 | 127,352.00 |
| Mar 31, 2023 | 129,350.00 |
| Sep 30, 2022 | -1,680.00 |
| Jun 30, 2022 | 188,495.00 |
| Mar 31, 2022 | 434,011.00 |
| Sep 30, 2021 | 3,352.00 |
| Jun 30, 2021 | 305,201.00 |
| Mar 31, 2021 | 532,715.00 |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | 6,448.00 |
| Jun 30, 2020 | 8,067.00 |
| Mar 31, 2020 | 11,690.00 |